Credit Suisse analyst Tayo Okusanya downgraded Healthcare Realty Trust to Neutral from Outperform with a price target of $20, down from $23. The analyst believes further merger synergies "may be slower to come." The firm is no "less enthusiastic" about Healthcare Realty’s future growth. The loss of the Healthcare Trust leasing team has it worried about the company’s ability to drive up occupancy in the portfolio, and it continues to worry about the impact of rising inflation on operating expenses.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HR:
- Healthcare Realty Trust Reports Results for the Fourth Quarter
- Healthcare Realty Trust reports Q4 normalized FFO 42c, consensus 40c
- Healthcare Realty Trust Announces Quarterly Dividend
- Healthcare Realty Trust completes $112.M in asset sales to fund special dividend
- Healthcare Realty Announces January Asset Sales to Complete Funding of Merger-Related Special Dividend